Epigenetic Regulation and Therapeutic Approaches in Cancer

Author(s): Felix Recillas-Targa

Journal Name: Current Topics in Medicinal Chemistry

Volume 8 , Issue 15 , 2008

Become EABM
Become Reviewer


The interdependency between genetic and epigenetic regulatory processes renders cancer therapeutics and translational clinic possible, even though they remain difficult tasks considering all the evidence supporting a central role of progenitor-stem cells as a causative source of cellular transformation. In contrast to genetic alterations, epigenetic processes are potentially reversible allowing a better action of complementary therapeutic compounds. Here I would first describe the plethora of interconnected epigenetic processes and targets to then discuss several therapeutic strategies on the basis of different compounds. I conclude that the advent of new and specific epigenetic target drugs will certainly contribute to better treatments and to the development of predictive protocols in a next future.

Keywords: Epigenetics, genetics, chromatin, chromatin remodelling, DNA methylation, cancer, inhibitors, therapies

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Page: [1367 - 1378]
Pages: 12
DOI: 10.2174/156802608786141179
Price: $65

Article Metrics

PDF: 5